Medical Treatment of Aortic Stenosis

被引:132
作者
Marquis-Gravel, Guillaume [1 ]
Redfors, Bjorn [2 ,3 ]
Leon, Martin B. [2 ,4 ]
Genereux, Philippe [1 ,2 ,4 ,5 ]
机构
[1] Univ Montreal, Hop Sacre Coeur Montreal, Montreal, PQ, Canada
[2] Cardiovasc Res Fdn, 1700 Broadway,9th Floor, New York, NY 10019 USA
[3] Sahlgrens Univ Hosp, Gothenburg, Sweden
[4] Columbia Univ, Med Ctr, New York, NY USA
[5] Morristown Med Ctr, Morristown, NJ USA
关键词
aortic valve; aortic valve stenosis; calcium; dyslipidemias; hypertension; medicine; stenosis; RENIN-ANGIOTENSIN SYSTEM; CONVERTING-ENZYME-INHIBITORS; LOW-DENSITY-LIPOPROTEIN; LEFT-VENTRICULAR HYPERTROPHY; CONGESTIVE-HEART-FAILURE; A REDUCTASE INHIBITORS; MATRIX GLA-PROTEIN; VALVE STENOSIS; RISK-FACTORS; CARDIOVASCULAR EVENTS;
D O I
10.1161/CIRCULATIONAHA.116.023997
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Untreated, severe, symptomatic aortic stenosis is associated with a dismal prognosis. The only treatment shown to improve survival is aortic valve replacement; however, before symptoms occur, aortic stenosis is preceded by a silent, latent phase characterized by a slow progression at the molecular, cellular, and tissue levels. In theory, specific medical therapy should halt aortic stenosis progression, reduce its hemodynamic repercussions on left ventricular function and remodeling, and improve clinical outcomes. In the present report, we performed a systematic review of studies focusing on the medical treatment of patients with aortic stenosis. Lipid-lowering therapy, antihypertensive drugs, and anticalcific therapy have been the main drug classes studied in this setting and are reviewed in depth. A critical appraisal of the preclinical and clinical evidence is provided, and future research avenues are presented.
引用
收藏
页码:1766 / 1784
页数:19
相关论文
共 165 条
[11]  
Ardehali R, 2012, J HEART VALVE DIS, V21, P337
[12]   Aortic Valve: Mechanical Environment and Mechanobiology [J].
Arjunon, Sivakkumar ;
Rathan, Swetha ;
Jo, Hanjoong ;
Yoganathan, Ajit P. .
ANNALS OF BIOMEDICAL ENGINEERING, 2013, 41 (07) :1331-1346
[13]   Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons [J].
Aronow, WS ;
Ahn, C ;
Kronzon, I ;
Goldman, ME .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (06) :693-695
[14]   PROGNOSIS OF CONGESTIVE-HEART-FAILURE IN PATIENTS AGED GREATER-THAN-OR-EQUAL-TO 62 YEARS WITH UNOPERATED SEVERE VALVULAR AORTIC-STENOSIS [J].
ARONOW, WS ;
AHN, C ;
KRONZON, I ;
NANNA, M .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (11) :846-848
[15]   Lipoprotein(a) Levels, Genotype, and Incident Aortic Valve Stenosis A Prospective Mendelian Randomization Study and Replication in a Case-Control Cohort [J].
Arsenault, Benoit J. ;
Boekholdt, S. Matthijs ;
Dube, Marie-Pierre ;
Rheaume, Eric ;
Wareham, Nicholas J. ;
Khaw, Kay-Tee ;
Sandhu, Manjinder S. ;
Tardif, Jean-Claude .
CIRCULATION-CARDIOVASCULAR GENETICS, 2014, 7 (03) :304-310
[16]   Impact of High-Dose Atorvastatin Therapy and Clinical Risk Factors on Incident Aortic Valve Stenosis in Patients With Cardiovascular Disease (from TNT, IDEAL, and SPARCL) [J].
Arsenault, Benoit J. ;
Boekholdt, S. Matthijs ;
Mora, Samia ;
DeMicco, David A. ;
Bao, Weihang ;
Tardif, Jean-Claude ;
Amarenco, Pierre ;
Pedersen, Terje ;
Barter, Philip ;
Waters, David D. .
AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (08) :1378-1382
[17]  
AWAN N, 1977, BRIT HEART J, V39, P651
[18]   BENEFICIAL-EFFECTS OF NITROPRUSSIDE ADMINISTRATION ON LEFT-VENTRICULAR DYSFUNCTION AND MYOCARDIAL ISCHEMIA IN SEVERE AORTIC-STENOSIS [J].
AWAN, NA ;
DEMARIA, AN ;
MILLER, RR ;
AMSTERDAM, EA ;
MASON, DT .
AMERICAN HEART JOURNAL, 1981, 101 (04) :386-394
[19]   Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis [J].
Bang, Casper N. ;
Greve, Anders M. ;
Kober, Lars ;
Rossebo, Anne B. ;
Ray, Simon ;
Boman, Kurt ;
Nienaber, Christoph A. ;
Devereux, Richard B. ;
Wachtell, Kristian .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 175 (03) :492-498
[20]   Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community [J].
Bellamy, MF ;
Pellikka, PA ;
Klarich, KW ;
Tajik, AJ ;
Enriquez-Sarano, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (10) :1723-1730